Merck Investors Urged to Act Before April 14 on Class Action

Merck Investors Urged to Act Before April 14 on Class Action

2025-04-03 companies

New York, Wednesday, 2 April 2025.
Merck & Co. investors with losses over $100,000 are advised to secure legal counsel by April 14, 2025, due to a securities class action alleging misleading Gardasil revenue projections.

Multiple prominent law firms, including Rosen Law Firm and Bronstein, Gewirtz & Grossman, LLC, have filed class action lawsuits against Merck & Co., Inc. (NYSE: MRK) covering the period from February 3, 2022, to February 3, 2025 [1][3]. The legal actions center on allegations that Merck provided materially false and misleading statements regarding projected revenue of $11 billion from Gardasil sales by 2030, particularly concerning demand in China [2].

Stock Impact and Financial Implications

The controversy came to a head on February 4, 2025, when Merck announced it would cease Gardasil shipments to China through at least mid-2025. This announcement triggered a significant market reaction, with Merck’s stock price dropping from $99.79 to $90.74, representing a decline of 9.069% [4]. The company attributed this decision to inflated channel inventories and acknowledged that demand in China had not recovered to expected levels [5].

The Rosen Law Firm, which secured over $438 million for investors in 2019 and ranked No. 1 for securities class action settlements in 2017, is leading efforts to represent affected investors [2][6]. Importantly, investors can seek compensation without upfront costs through contingency fee arrangements [4]. The lawsuit particularly affects those who purchased Merck securities during the specified class period and suffered losses [1].

Next Steps for Investors

With the April 14, 2025 deadline approaching, potential class members are encouraged to act promptly to preserve their rights [1][2][3]. While no class has yet been certified, investors have the option to select their own counsel [5]. Those interested in joining the class action can submit their information through dedicated online portals or contact the representing law firms directly [2].

Sources


lawsuit Merck